S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

Eton Shares Jump 12% as Quarterly Revenue More Than Doubles

Eton Pharmaceuticals shares climbed 12% to $52.59 on Friday after the company reported third-quarter revenue of $57.9 million, more than twice the year-earlier level, and raised its full-year revenue outlook.

Eton Shares Jump 12% as Quarterly Revenue More Than Doubles

Eton posted a third-quarter profit of $35.2 million, or $1.06 a share, compared with a loss of $1.9 million, or 7 cents a share, a year earlier. Analysts surveyed by FactSet had expected earnings of 31 cents a share. Adjusted earnings were 50 cents a share.

Revenue of $57.9 million topped analyst estimates of $42 million. Chief Executive Sean Brynjelsen said the company exceeded its goal of reaching a $200 million annualized revenue run rate five quarters ahead of schedule, citing strong growth across its portfolio.

Eton raised its revenue guidance for the year to more than $175 million, from its previous outlook of more than $145 million. The shares have more than tripled year to date.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!